The CD112R/CD112 axis: a breakthrough in cancer immunotherapy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, September 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,898 followers.

RT @JournalofExper1: New Review! 💣 𝐓𝐡𝐞 𝐂𝐃𝟏𝟏𝟐𝐑/𝐂𝐃𝟏𝟏𝟐 𝐚𝐱𝐢𝐬: 𝐚 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 Have a look here 👇 https://t.co/5MaNyHg…

New Review! 💣 𝐓𝐡𝐞 𝐂𝐃𝟏𝟏𝟐𝐑/𝐂𝐃𝟏𝟏𝟐 𝐚𝐱𝐢𝐬: 𝐚 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 Have a look here 👇 https://t.co/5MaNyHglqb #ImmuneCheckpoints @IREISGufficiale https://t.co/cNvCIOxLDQ

The CD112R/CD112 axis: a breakthrough in cancer immunotherapy by Taofei Zeng https://t.co/iRCrT9HiR8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.